Articles tagged with Mutation
A research group from Ben-Gurion University of the Negev has identified genetic mutations in the GUCY2C gene that cause intestinal blockages in newborns from two Bedouin tribes in Israel. The mutations may have evolved to protect against diarrheal diseases in the harsh desert climate.
Researchers at Columbia University Medical Center presented studies on the impact of large-vessel acute ischemic stroke on cerebral blood vessels and found that dynamic cerebral autoregulation is impaired after the event, but normalizes by week two. Additionally, they discovered increased regional expression of Lingo-1 in the essential...
Researchers have identified a rare gene mutation in the CARD14 gene that is directly linked to plaque psoriasis, accounting for 80% of all cases. The discovery may lead to more effective treatments and sheds light on the genetic pathway underlying the condition.
Researchers identified CHD8, SNC2A, and KATNAL2 gene mutations as risk factors for autism. The studies provide a better understanding of the genetic changes and biological pathways involved in autism spectrum disorders.
A recent study by Yale University researchers found that approximately 15% of autism cases in families with a single autistic child are associated with spontaneous genetic mutations. The study analyzed DNA sequencing data from 238 families and identified hundreds of de novo sequence variations linked to an increased risk for autism.
Researchers propose that non-genetic resistance can occur before genetic mutations, changing the approach to designing combination therapies. This new perspective aims to improve outcomes by understanding how cancers evolve and adapt to extreme challenges.
Researchers reveal a genetic mutation behind the distinctive double-flowered sunflowers depicted in Van Gogh's paintings, which has been hidden for over a century. The study identifies a disrupted gene responsible for creating the mutated trait.
Researchers identified the genetic basis of a mutation in sunflowers that results in double-flowered varieties depicted by Van Gogh. The study found a single dominant gene responsible for creating the mutation, which disrupts the production of ray florets.
Researchers have discovered a genetic mutation that causes familial chronic diarrhea syndrome, which could lead to new treatments for similar conditions. The mutation affects the GUCY2C gene, leading to constant signaling in the intestines and potentially causing inflammation and diarrhea.
Scientists at the University of Nottingham used next-generation DNA sequencing to correct a patient's genetic diagnosis from incorrect to accurate. The new technique enables fast and affordable analysis of human genomes, providing hope for thousands of people living with muscle-wasting diseases in the UK.
A research team including Iowa State University chemists has found that genetic mutations to cellulose in plants can improve the conversion of cellulosic biomass into biofuels. The team discovered that mutated plant cell walls produce less crystalline cellulose, making it easier to break down into fermentable sugars.
Researchers at the University of Warwick discovered that cancer-causing genetic mutations exhibit distinct electronic properties, making them harder to detect. These mutations can be compared to stealth technology used in radar systems, which allows them to go undetected by the body's defense mechanisms.
A new study has mapped the genome of a Quarter Horse mare using next-generation sequencing, revealing genetic variants associated with sensory perception, signal transduction, and immunity. The research found that Quarter Horses have more genetic variation than Thoroughbreds, particularly in genes involved in these traits.
A new study confirms that synaptic protein mutations increase the risk of autism spectrum disorders (ASDs), emphasizing the importance of synaptic gene dysfunction and modifier genes. The research identifies mutations in the SHANK2 gene and highlights its role in neuronal function and interaction with other genetic variations.
Researchers at Yale University have discovered a new gene mutation that provides hope for new screening methods to identify women at risk of developing endometriosis. The study found that 31% of women with endometriosis carried the mutation, compared to 5.8% of the general population.
A new web-based application, Pyromaker, has been developed to accurately identify complex genetic mutations. The tool uses simulated pyrograms to generate a virtual trace of the expected signal, allowing for clearer interpretation of ambiguous results from current testing methods.
A Canadian-led research team has identified two genetic mutations responsible for up to 40% of glioblastomas in children, a fatal cancer of the brain. The mutations were found to be involved in DNA regulation, which could explain resistance to traditional treatments and have significant implications on other cancers.
Researchers have identified a rare, inherited mutation linked to a significantly higher risk of developing prostate cancer. The mutation was found in 10-20 times more men who inherited it compared to the general population. Further studies may lead to genetic testing for inherited prostate cancer.
A genetic mutation in the PLCG2 gene causes a rare immune disorder characterized by excessive and impaired immune function, leading to symptoms such as cold-induced hives, immune deficiency, and autoimmunity. The study identifies a unique genetic mechanism at the crux of allergy, immune defense, and self-tolerance.
Researchers identified genetic mutations in OATP1B1 and OATP1B3 proteins as the underlying cause of Rotor syndrome, a condition characterized by conjugated bilirubin buildup. Complete deficiency of these proteins can cause hypersensitivity to certain drugs and interrupt conjugated bilirubin reuptake into the liver.
A UCSF-led team has identified the gene PRRT2 as the cause of a rare childhood neurological disorder called PKD/IC. The study may improve diagnosis and shed light on other movement disorders like Parkinson's disease.
A new study identified a gene mutation that dates back to 11,600 B.C. and causes a rare vitamin B12 deficiency called Imerslund-Gräsbeck Syndrome. The mutation was found in people of Arabic, Turkish, and Jewish ancestry and is believed to have originated in a single prehistoric individual.
Researchers have identified a critical genetic mutation in patients with myelodysplastic syndromes, which can progress to leukemia. The mutation is found in nearly 9% of patients, increasing the risk of developing acute leukemia by almost three times. The study raises hopes for improved diagnosis and treatment of this blood cancer.
Researchers halt progressive neuron degeneration in rat model of familial ALS by switching off mutant TDP-43 expression. Recovery is possible if intervention occurs before significant motor neuron degeneration.
A multidisciplinary team approach to genetic testing in retinoblastoma patients ensures timely evaluation and appropriate counseling, improving risk prediction for patients and family members. Genetic testing also prevents overutilization of clinical screening tests, reducing potential morbidity for relatives.
A new clinical test called SNaPshot allows doctors to identify patients' individual genotypes and target tumours with the most appropriate therapy. The test has been shown to significantly improve response rates in non-small-cell lung cancer patients.
Researchers identified a genetic mutation causing CANDLE, a spectrum of diseases characterized by inflammation, fat loss, and elevated temperatures. The discovery may lead to the development of new treatments targeting the interferon pathway.
A new international study found that women without genetic mutations but closely related to those who do have them are at an average risk of developing breast cancer. This contradicts previous claims that all women in such families share a high risk, according to Professor John Hopper from the University of Melbourne.
A population-based analysis found that close relatives of women with breast cancer who don't carry the BRCA mutation have a similar risk to the general population. The study suggests they may not need extra cancer screening and preventive measures.
A Scripps Research scientist has been awarded a $500,000 grant to study the genetic mutations associated with Parkinson's disease. The researcher will investigate two genes, LRRK2 and SGK1, which have shown a link between their mutations and reduced risk of Parkinson's disease.
A study found that women with BRCA2 genetic mutations experienced significantly better overall survival rates (61") compared to those without the mutation (25"). Additionally, BRCA2-mutated patients demonstrated longer progression-free survival durations and higher primary chemotherapy sensitivity rates
Researchers analyzed SEC23B gene mutations in CDA II patients and found that two variants, R14W and E109K, are more common in Italian population. The R14W variant is believed to have originated 3,000 years ago in Southern Italy, while E109K may have originated in the Middle East around 2,400 years ago.
Researchers develop a comprehensive genetic model that integrates various types of genetic variation, including single gene changes, chromosomal alterations, and de novo mutations. This framework recognizes the importance of both inherited and new genetic variants in disease susceptibility.
Researchers at Mayo Clinic identified mutations linked to immune response to the measles vaccine, which could enable physicians to prescribe appropriate doses and timing based on routine genetic screening blood tests. The study's findings also have implications for the development of more effective vaccines and personalized vaccination.
A gene for Lou Gehrig's disease and frontotemporal dementia has been identified by researchers at the University of California - San Francisco. The mutated gene, C9ORF72, is associated with nearly 12% of familial cases and over 22% of sporadic cases of the diseases., Scientists have discovered a genetic mutation that triggers both Lou ...
A new genetic mutation has been discovered in the C9ORF72 gene, responsible for over a third of familial ALS cases. The repeated DNA sequence causes toxic RNA buildup, leading to motor neuron demise and disease progression.
Researchers at Tel Aviv University identified the genetic defect responsible for adermatoglyphia, a rare condition where individuals lack fingerprints. The study found that a skin-specific gene mutation affects fingerprint development, leading to reduced sweat gland function and abnormal fingerprints.
A new diagnostic method using exome deep sequencing can identify genetic causes of hearing loss in under a week for under $500. This breakthrough technology has the potential to improve the quality of care for patients with hearing loss and lead to more effective treatments.
Researchers identified six critical mutations in Israeli Jewish and Palestinian Arab families using exome sequencing, revealing new insights into hereditary deafness. The study also found a specific TMC1 mutation associated with hearing loss in the Moroccan Jewish population.
A newly discovered gene mutation in EIF4G1 has been linked to Parkinson's disease, affecting protein translation and cellular recycling. This finding provides a new potential target for treatments and highlights the importance of gene-environmental interactions in neurodegenerative diseases.
A recent study discovered that a PSMB8 gene mutation causes Japanese autoinflammatory syndrome with lipodystrophy. The researchers identified the specific mechanism of the mutation and its impact on human health.
Researchers at the University of Helsinki identified specific mutations in the MED12 gene as the cause of fibroid tumorigenesis in 70% of studied tumors. This discovery provides hope for targeted therapies and a deeper understanding of fibroid development.
A clinician-scientist team, led by Joseph M. Miano and Craig Benson, has created a model resource that identifies and outlines the function of common mutations in the human genome. They believe this information will help guide the development of new prevention and treatment options for diseases.
A University of Iowa research team discovered a new genetic cause of retinitis pigmentosa by analyzing DNA sequencing and induced pluripotent stem cells. The study identified a mutation in the MAK gene as the likely cause of the disease, which affects about 1 in 4,000 people in the US.
Researchers found that new mutations, separate from inherited mutations, significantly contribute to the occurrence of schizophrenia. This discovery highlights the significance of personal genome sequencing in understanding complex diseases like schizophrenia.
Researchers have found that de novo protein-altering mutations account for more than 50% of sporadic schizophrenia cases. These genetic errors are present in patients but not in their parents. The study suggests that many more mutations may contribute to the disease, paving the way for new treatments.
Scientists have identified a rare genetic mutation that underlies adermatoglyphia, a condition characterized by the complete absence of fingerprints. The study provides valuable insight into the genetics of fingerprint formation and highlights the usefulness of rare genetic mutations in understanding human biology.
Researchers discovered genetic changes in the mitochondrial genome of iPS cells, which can cause metabolic disorders and nervous diseases. The study highlights the need to test cell lines intended for clinical use for such mutations.
Researchers have identified genetic mutations in patients with Barrett's esophagus and esophageal adenocarcinoma, linking a heritable cause to the disease. Three genes, MSR1, ASCC1, and CTHRC1, were found to be mutated in 11% of BE/EAC patients, suggesting a significant genetic predisposition.
Mutations in MSR1, ASCC1, and CTHRC1 genes are linked to increased risk of esophageal adenocarcinoma and Barrett esophagus, a premalignant condition caused by chronic GERD. The study found that these three genes accounted for 11 percent of cases, highlighting the potential importance of genetic testing in risk assessment.
Researchers have identified detectable changes in biological markers in the spinal fluid up to 20 years before dementia onset. Participants with inherited Alzheimer's mutations exhibit lower amyloid beta and higher tau protein levels in their cerebrospinal fluid, indicating potential for prevention trials.
Researchers at Mayo Clinic discovered a genetic mutation in VPS35 that causes Parkinson's disease, leading to protein buildup in the brain. This finding opens up new avenues for understanding and treating the complex disease.
Researchers discovered seven new genes linked to Ankylosing Spondylitis, bringing the total to thirteen known predisposing genes. The study also revealed an interaction between genetic mutations HLA-B27 and ERAP1, providing insight into the disease's cause.
Researchers at Brigham and Women's Hospital developed a method to predict MDS patient survival by identifying specific gene mutations in their abnormal bone marrow. Nearly a third of patients had mutations in one or more prognostic genes, which could guide treatment decisions.
A research team has identified the disease-causing mutation in a newly characterized rare genetic disease using DNA from just a few individuals. The VAAST tool, developed by Mark Yandell and Martin G. Reese, uses rapid and accurate gene-sequencing techniques to pinpoint mutations in individual patients.
A study by Massachusetts General Hospital researchers reveals that disruption of the molecular pathway causing Gaucher disease leads to toxic α-synuclein deposits in Parkinson's disease. This finding indicates therapies targeting this pathway may be a new option for patients with Parkinson's disease.
Researchers from the University of Pittsburgh and UW-Madison traced how a specific gene became activated in optical neurons of a fruit fly species over four mutations. They found that small alterations in transcriptional enhancers caused 'leaky' gene activity, leading to the development of a new trait.
Research suggests that many hereditary conditions are linked to errors in pre-mRNA splicing, which can be addressed through new therapies. A computer analysis predicts that 22 percent of genetic mutations may affect splicing, implying hundreds of hereditary diseases could be linked to this issue.
Researchers have discovered new gene mutations in CLL patients, linking NOTCH1 pathway to poorer prognosis and shorter survival. The findings suggest the potential for diagnostic and therapeutic purposes in human CLL.
Researchers have discovered a chromosomal mutation responsible for a very rare condition called CGH, which causes individuals to grow excess hair on their bodies. The study found that the insertion of chromosome 5 into the X chromosome appears to turn on a gene, likely SOX3, leading to excessive hair growth.